FDA expands emergency use for Pfizer’s COVID-19 vaccine for children

FDA Expands EmergencyUse for Pfizer’s COVID-19Vaccine for Children.Pfizer’s COVID-19 vaccine for children aged 12 to 15 hasreceived emergency use authorization in the United States. .An analysis of 1,005 participants in the age group found the vaccine to be 100 percent effective at preventing COVID-19. .Pfizer’s vaccine is still the only one to beapproved so far for children aged 16 to 18. .According to FDA actingcommissioner Janet Woodcock,adolescents will receive the same dosage and regimen as adults. .This will allow for vaccine distribution sitesto simply “extend down to the younger age group” and provide access to millions of adolescents.Today's action allows for ayounger population to beprotected from COVID-19,bringing us closer to returningto a sense of normalcy and toending the pandemic, Janet Woodcock, via CBS News